PRESS RELEASE For immediate release DEVONIAN ANNOUNCES THE ISSUANCE OF UNITS IN SETTLEMENT OF INTERESTS OWED TO DEBENTURE HOLDERS . QUEBEC, September 7, 2022 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD; OTCQB: DVHGF), a clinical stage...
Press Releases
DEVONIAN ANNOUNCES EXECUTIVE CHANGES, GRANT OF STOCK OPTIONS AND SETTLEMENT OF INTERESTS AND REPAYMENT OF PRINCIPAL AMOUNT OWED TO A DEBENTURE HOLDER
PRESS RELEASE For immediate release DEVONIAN ANNOUNCES EXECUTIVE CHANGES, GRANT OF STOCK OPTIONS AND SETTLEMENT OF INTERESTS AND REPAYMENT OF PRINCIPAL AMOUNT OWED TO A DEBENTURE HOLDER. Executive changes announced in support of the Corporation Growth Phase: Ms. Sybil...
Devonian Health Group Announces the Journal of Drugs in Dermatology acceptance for publication of Thykamine™ positive phase 2 clinical trial results in Atopic Dermatitis
PRESS RELEASE For immediate release Devonian Health Group Announces the Journal of Drugs in Dermatology acceptance for publication of Thykamine™ positive phase 2 clinical trial results in Atopic Dermatitis. QUEBEC, May 26, 2022 – Devonian Health Group Inc....
Devonian Announces Adoption of Restricted Share Unit Plan
PRESS RELEASE For immediate release Devonian Announces Adoption of Restricted Share Unit Plan. QUEBEC, March 17th, 2022 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD ; OTCQB : DVHGF), a clinical stage botanical pharmaceutical...
Devonian Health Group Announces trading on the OTCQB® Market under symbol DVHGF
PRESS RELEASE For immediate release Devonian Health Group Announces trading on the OTCQB® Market under symbol DVHGF. QUEBEC, March 10, 2022 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical pharmaceutical...
DEVONIAN ANNOUNCES THE ISSUANCE OF UNITS IN SETTLEMENT OF INTERESTS OWED TO DEBENTURE HOLDERS
PRESS RELEASE For immediate release DEVONIAN ANNOUNCES THE ISSUANCE OF UNITS IN SETTLEMENT OF INTERESTS OWED TO DEBENTURE HOLDERS. QUEBEC, March 7, 2022 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a clinical stage botanical...
Devonian Health Group Announces voting results of the Annual General and Special Meeting and welcome new board members
PRESS RELEASE For immediate release Devonian Health Group Announces voting results of the Annual General and Special Meeting and welcome new board members. QUEBEC, – March 1st , 2022 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD), a...
DEVONIAN ANNOUNCES THE ISSUANCE OF UNITS IN SETTLEMENT OF INTERESTS OWED TO A DEBENTURE HOLDER AND GRANT OF STOCK OPTIONS
PRESS RELEASE For immediate release DEVONIAN ANNOUNCES THE ISSUANCE OF UNITS IN SETTLEMENT OF INTERESTS OWED TO A DEBENTURE HOLDER AND GRANT OF STOCK OPTIONS. QUEBEC, January 31st, 2022 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXv: GSD),...
Devonian Announces Adoption of Shareholder Rights Plan and Modification to a Private Placement
PRESS RELEASE For immediate release Devonian Announces Adoption of Shareholder Rights Plan and Modification to a Private Placement. Not for distribution to United States newswire services or for dissemination in the United States QUEBEC, January 27, 2022...
Devonian Health Group Announces Application for OTCQB listing
PRESS RELEASE For immediate release Devonian Health Group Announces Application for OTCQB listing. QUEBEC, January 11, 2022 – Devonian Health Group Inc. (“Devonian” or the “Corporation”) (TSXV: GSD), a clinical stage botanical pharmaceutical corporation,...